Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) insider Peter Heerma sold 4,980 shares of the stock in a transaction that occurred on Wednesday, December 24th. The stock was sold at an average price of $40.00, for a total transaction of $199,200.00. Following the transaction, the insider owned 113,013 shares in the company, valued at […]

Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) CAO Sandra Calvin sold 7,402 shares of the business’s stock in a transaction that occurred on Wednesday, December 24th. The shares were sold at an average price of $40.00, for a total transaction of $296,080.00. Following the completion of the transaction, the chief accounting officer owned 38,233 […]

Sionna Therapeutics, Inc. (NASDAQ:SION – Get Free Report) Director Peter Thompson sold 33,356 shares of the business’s stock in a transaction that occurred on Wednesday, December 24th. The shares were sold at an average price of $44.55, for a total value of $1,486,009.80. Following the completion of the sale, the director directly owned 3,561,655 shares […]

Galectin Therapeutics Inc. (NASDAQ:GALT – Get Free Report) insider Khurram Jamil sold 19,442 shares of the firm’s stock in a transaction dated Wednesday, December 17th. The stock was sold at an average price of $7.04, for a total value of $136,871.68. The sale was disclosed in a filing with the Securities & Exchange Commission, which […]

Rapport Therapeutics, Inc. (NASDAQ:RAPP – Get Free Report) CEO Abraham Ceesay sold 5,833 shares of the stock in a transaction that occurred on Wednesday, December 17th. The shares were sold at an average price of $29.64, for a total transaction of $172,890.12. Following the transaction, the chief executive officer owned 567,913 shares in the company, […]